Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel in Systemic Lupus Erythematous
NCT02320357Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clopidogrel in systemic lupus erythematosus (SLE), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Measurements of plasmatic soluble CD40 Ligand levels at 12 weeks. Started Aug 2015; status: completed.
02
Drugs
clopidogrel
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02320357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02320357.